Singapore is accelerating the pace in our national COVID-19 vaccination programme to extend vaccination to more segments of the population. As shared by MOH on 16 March 2021, earlier vaccination for patients with complex chronic medical conditions will be offered at hospitals and clinics, as these patients are more vulnerable to severe complications if they were to fall ill with COVID-19.
To support the national effort, SingHealth will be offering vaccination to
inpatients and outpatients with complex medical conditions at our institutions, if they are medically eligible and have not received vaccination.
Our doctors will assess and discuss with the patients if they are eligible for vaccination.
Patients do not need to contact SingHealth institutions to make a separate appointment.
Here’s a quick overview of an outpatient’s vaccination journey if offered the COVID-19 vaccination at one of SingHealth’s institutions.
Getting vaccinated against COVID-19 is a key and effective measure in the national strategy to contain the current pandemic.
If you have not been vaccinated and are medically eligible, your doctor may offer you the option of receiving your COVID-19 vaccination at the healthcare institution at which you are on medical follow-up.
Your doctor will screen and review your medicine to ensure that you are suitable to receive the COVID-19 vaccine.
If you are medically eligible, registration staff at the clinic will help you book appointments for Doses 1 and 2 of the COVID-19 vaccination. The appointment for Dose 1 may not be on the same day that your doctor refers you for the vaccination.
You will receive SMS confirmations one week before and on the day of your vaccination appointments.
Manage your Medical Appointments with
*If you are unable to keep to your appointment, please reschedule as soon as possible.
Please continue to observe current safe management measures to keep yourself and your loved ones protected.
Please note: If you need to reschedule your appointment, please refer to the instructions within the SMS notification or do so via the
HealthBuddy app as soon as possible.
After vaccination: Like other vaccines, this vaccine may cause mild or moderate side effects in some individuals (please see the list of side effects below). These will usually get better within a few days. You may wish to see a doctor if the side effects persist or get worse.
See SingHealth Outpatient COVID-19 Vaccination Roadmap poster
More information on the COVID-19 vaccine is available at
The vaccine is free for all Singaporeans and long-term residents in Singapore, which includes Singapore Permanent Residents, and Employment Pass holders.
You will be getting either the Pfizer-BioNTech or ComirnatyTM vaccine.
ComirnatyTM vaccine – this vaccine is the same as the Pfizer-BioNTech vaccine that Singapore has been using in our national vaccination programme, with the same research name BNT162b2. They are manufactured according to the same processes and procedures, and meet the same finished product specifications as the Pfizer-BioNTech vaccines. They are similarly manufactured in Europe and shipped directly to Singapore. The only difference is in their label. Please see
MOH’s press release for more information.
The vaccine consists of two doses, with the second dose due approximately 28 to 56 days apart after the first dose. You must receive both doses to have the full vaccine protection.
The vaccine will be injected in your upper arm. To make this easier, you are advised to wear short-sleeved attire, or sleeves loose enough to be rolled up.
You may not be able to obtain an appointment on the same day. Vaccination appointments must be booked in advance to ensure that we order the vaccine for you.
As different vaccination centres may use different brands of the COVID-19 vaccine, you should return to the same vaccination centre for the second dose where you received the first dose of the vaccine. Hence, if you opt for COVID-19 vaccination with us, please return here for your second dose. At the point of enrolment, we will help you make the appointments for both Dose 1 and Dose 2.
The vaccine has been assessed to be safe. However, you may experience common side effects, similar to other vaccines. Most side effects are mild or moderate, and usually get better within a few days. The table below lists some common side effects that have been reported with this vaccine, and how to manage them.
See a doctor if:
In very rare cases, this vaccine can cause a severe allergic reaction. Signs of a severe allergic reaction include: difficulty breathing, swelling of your face, throat, eyes or lips, a fast heartbeat, dizziness and weakness, a bad rash all over your body. If you experience a severe allergic reaction, seek medical attention immediately. Call 995 or go to the nearest A&E immediately.
The vaccine injury financial assistance programme (VIFAP) by MOH will provide financial assistance to Singapore Citizens, Permanent Residents and Long-Term Pass holders vaccinated under the national vaccination programme, in the rare event that a person suffers from serious side effects that are assessed to be related to their COVID-19 vaccination.
To apply for VIFAP, individuals will need to submit an application accompanied by medical information on the serious side effect from their treating doctor. All applications will be reviewed by an independent clinical panel for the relatedness and severity of the side effect(s) to the COVID-19 vaccine received.
More information on how to apply can be found at www.moh.gov.sg/covid-19/vaccination/vifap.
The physical vaccination card that is given to all vaccinated individuals is not meant to be used for travel purposes. Relevant government agencies are engaging international counterparts and monitoring global developments on the issuance and recognition of digital vaccination certificates for travel purposes, as part of ongoing efforts to reopen the economy and enable cross border travel. More details will be shared when available.
More information on the COVID-19 vaccine is also available at www.moh.gov.sg/covid-19/vaccination.
Subscribe to our mailing list to get the updates to your inbox